The company's prospectus dated Feb. 6, 2020, was filed with and accepted by the TSX Venture Exchange, and filed with and receipted by the securities commissions of Alberta, British Columbia, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, and Autorite des marches financiers du Quebec, pursuant to the provisions of the Alberta, British Columbia, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, and Quebec securities acts.

Underwriter:  Echelon Wealth Partners Inc.

Offering:  The offering consists of 29,245,300 units at the price of 53 cents per unit. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at the exercise price of 75 cents per share during a period of 36 months following the closing date.

Offering price:  53 cents per unit

Warrant exercise price:  75 cents per share at any time prior to 5 p.m. Toronto time on the date that is 36 months following the closing date of the offering

Underwriter's fee:  up to 7 per cent of the gross proceeds of the offering in cash and a number of warrants equal to 7 per cent of the number of units sold pursuant to the offering, including the additional units that may be issued under the overallotment option (Each underwriter's warrant entitles the holder thereof to acquire one common share for an exercise price of 75 cents per common share for a period of 36 months following the closing date.)

Overallotment option:  The company granted to the underwriter an option to purchase additional units, at the subscription price, for a maximum number equal to 15 per cent of the number of units sold under the offering for a period of 30 days from the closing date of the offering.

The exchange has been advised that a total of 29,245,300 units have been issued at a price of 53 cents per unit pursuant to the closing of the offering, for aggregate gross proceeds of $15,500,009. Up to an additional 4,386,795 units may be issued under the overallotment option.

Effective at the opening on Tuesday, Feb. 25, 2020, the warrants of the company will be listed and admitted to trading on the TSX Venture Exchange. The issuer is classified as a pharmaceutical and medicine manufacturing issuer (NAICS No. 325410).

Corporate jurisdiction:  Canada

Capitalization:  31,292,471 warrants issued and outstanding, of which 2,047,171 were issued as part of the underwriter's fee; up to an additional 4,693,870 warrants could be issued upon exercise of an overallotment option granted pursuant to the company's prospectus dated Feb. 6, 2020

Warrants exercise price:  75 cents per share at any time prior to 5 p.m. Toronto time on the date that is 36 months following the closing date of the offering (The expiry date of the warrants is Feb. 13, 2023, as per the warrant indenture.)

Transfer agent:  Computershare Trust Company of Canada -- Montreal and Toronto

Trading symbol:  TBP.WT.B

Cusip No.:  88166Y134

The warrants will be governed by the terms of an indenture executed on Feb. 13, 2020, between the issuer and Computershare Trust Company of Canada -- Montreal and Toronto, as warrant agent.

The warrants were issued pursuant to a prospectus dated Feb. 6, 2020, of 29,245,300 units at a price of 53 cents per unit. Each unit consists of one common share and one warrant. Each warrant entitles the holder to purchase one common share of the company at a price of 75 cents per common share and will expire at 5 p.m. Toronto time on the date that is 36 months following the closing date of the offering. The company granted to the underwriter an option to purchase units, at the subscription price, for a maximum number equal to 15 per cent of the number of units sold under the offering for a period of 30 days from the closing date of the offering.